REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmavaccine S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmavaccine S.A. Profile Updated: April 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Pharmavaccine S.A. is an enterprise located in Ecuador, with the main office in Guayaquil. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on October 01, 2010. It currently has a total number of 7 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 48.41% in 2023. Over the same period, its total assets grew by 37.34%. The enterprise’s net profit margin increased by 1.24% in 2023.

Headquarters
Piedrahita 347 , Floor 1
Guayaquil; Guayas;

Contact Details: Purchase the Pharmavaccine S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmavaccine S.A. report to view the information.
Outstanding Shares:
Purchase the Pharmavaccine S.A. report to view the information.
Registered Capital:
Purchase the Pharmavaccine S.A. report to view the information.
Incorporation Date:
October 01, 2010
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.9%
Purchase this report to view the information.
0.1%
Company Performance
Financial values in the chart are available after Pharmavaccine S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
48.41%▲
Total operating revenue
48.41%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
81.07%▲
Total assets
37.34%▲
Total equity
10.51%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1.24%▲
Return on Equity (ROE)
9.91%▲
Quick Ratio
-2.15%▼
Cash Ratio
-1.25%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo